000 | 00972nam a2200265 4500 | ||
---|---|---|---|
003 | KMLcat | ||
008 | 160311b xxu||||| |||| 00| 0 eng d | ||
020 | _a9789241564175 | ||
041 | _aEng | ||
082 |
_a615.1 _bENS |
||
245 |
_aEnsuring balance in national policies on controlled substances _bguidance for availability and accessibility of controlled medicines |
||
260 |
_c2011 _aGeneva _bWHO _g2011 |
||
300 |
_av, 78 p. _c30 cm. _eCD |
||
650 | _aDRUG AND NARCOTIC CONTROL | ||
655 |
_aDrug and narcotic control _910656 |
||
655 |
_aEssential drugs - supply and distribution _911749 |
||
655 |
_aGuidelines _94505 |
||
655 |
_aHealth policy _919752 |
||
655 |
_aHuman rights _99777 |
||
655 |
_aLegislation, medical _913915 |
||
655 |
_aLegislation, pharmacy _913916 |
||
655 |
_aOpioid related disorders - prevention and control _913917 |
||
856 | _uhttp://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/ | ||
942 |
_cSPR _2ddc |
||
999 |
_c5473 _d5473 |